Trendelenburg, Abdominal Insufflation and Time to Completion of Cystoscopy
NCT ID: NCT05786391
Last Updated: 2025-02-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
122 participants
INTERVENTIONAL
2023-04-11
2024-02-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators seek to compare the efficiency of the cystoscopy with two interventions:
1. patient position during the cystoscopy (Trendelenburg (head down) or flat)
2. Abdominal insufflation (insufflation versus no insufflation)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Prediction of Flexible Ureteroscopy Outcome in the Treatment of Renal Calculi
NCT05857501
Tip-flexible Semi-rigid Ureterorenoscope Versus Flexible Ureteroscopy in Renal Calculi
NCT02426931
Evaluation of Novel Disposable Flexible Ureteroscope for the Treatment of Renal Calculi
NCT05646069
Evaluation of Retrograde Intra Renal Surgery in the T-tilted Position
NCT06860113
Ureteral Stenting After Retrograde Intrarenal Surgery for Renal Stones
NCT05738304
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators seek to compare the efficiency of the cystoscopy with two interventions:
1. patient position during the cystoscopy (Trendelenburg (head down) or flat)
2. Abdominal insufflation (insufflation versus no insufflation).
Both interventions are used as usual care and depend on surgeon preference without evidence why one would be faster at completing the cystoscopy. Also note that these two interventions are performed multiple times during the surgery itself and outside the cystoscopy procedure routinely. The investigator's main objective is to assess which intervention or combination of interventions is more efficient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Flat position with no Insufflation
Flat position
Flat patient position during the cystoscopy
Trendelenburg position and Insufflation
insufflation to 15 mm Hg
Trendelenburg position
Trendelenburg position (head down) during the cystoscopy
Insufflation
Insufflation to 15 mm Hg
Flat position and Insufflation
Flat position
Flat patient position during the cystoscopy
Insufflation
Insufflation to 15 mm Hg
Trendelenburg position with no Insufflation
Trendelenburg position
Trendelenburg position (head down) during the cystoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flat position
Flat patient position during the cystoscopy
Trendelenburg position
Trendelenburg position (head down) during the cystoscopy
Insufflation
Insufflation to 15 mm Hg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Known urologic anomaly
* Unplanned cystoscopy
* Cancer surgery
* Urogynecology surgery
* comorbidities including cardiac disease, chronic hypertension, any stage kidney disease (including abnormal creatinine level), and use of diuretics.
* Undergoing extensive ureterolysis
* Blood loss more than 500 milliliters (mLs)
* Contra-indications to position change and insufflation
18 Years
90 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Randa Jalloul
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Randa Jalloul, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-MS-22-1081
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.